Yang, C.-F., Chan, D. Y., Yerokun, B., Wang, X. F., Tong, B. C., D’Amico, T. A., … Harpole, D. (2016). Surgery versus optimal medical management of early-stage small cell lung cancer. In Journal of Clinical Oncology (Vol. 34, pp. 8511–8511). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2016.34.15_suppl.8511

Yang, Chi-Fu Jeffrey, Derek Y. Chan, Babatunde Yerokun, Xiaofei F. Wang, Betty Caroline Tong, Thomas A. D’Amico, Mark W. Onaitis, Matthew G. Hartwig, Mark F. Berry, and David Harpole. “Surgery versus optimal medical management of early-stage small cell lung cancer.” In Journal of Clinical Oncology, 34:8511–8511. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.8511.

Yang C-FJ, Chan DY, Yerokun B, Wang XF, Tong BC, D’Amico TA, et al. Surgery versus optimal medical management of early-stage small cell lung cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. 8511–8511.

Yang, Chi-Fu Jeffrey, et al. “Surgery versus optimal medical management of early-stage small cell lung cancer.” Journal of Clinical Oncology, vol. 34, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2016, pp. 8511–8511. Crossref, doi:10.1200/jco.2016.34.15_suppl.8511.

Yang C-FJ, Chan DY, Yerokun B, Wang XF, Tong BC, D’Amico TA, Onaitis MW, Hartwig MG, Berry MF, Harpole D. Surgery versus optimal medical management of early-stage small cell lung cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. 8511–8511.